AUTOLUS THERAPEUTICS PLC - AMERICAN DEPOSITARY SHA

Autolus Therapeutics to hold Analyst call to highlight data at ASCO from the Pivotal Phase 2 FELIX study of obe-cel data in adult r/r B-ALL

22 May 2023 07:00:00 By Nasdaq GlobeNewswire

Autolus Therapeutics announces Pivotal Phase 2 FELIX study of obe-cel in adult r/r B-ALL selected for an oral presentation at EHA

12 May 2023 07:00:00 By Nasdaq GlobeNewswire

Autolus Therapeutics Reports First Quarter 2023 Financial Results and Operational Progress

04 May 2023 07:00:02 By Nasdaq GlobeNewswire

Autolus Therapeutics announces Pivotal Phase 2 FELIX study of obe-cel in adult r/r B-ALL selected for an oral presentation at ASCO

27 Apr 2023 07:01:00 By Nasdaq GlobeNewswire

Autolus Therapeutics Selects Cardinal Health as U.S. Commercial Distribution Partner

27 Apr 2023 07:00:00 By Nasdaq GlobeNewswire

Autolus Therapeutics Announces Publication in Molecular Therapy Nucleic Acids

26 Apr 2023 16:01:00 By Nasdaq GlobeNewswire

Autolus Therapeutics Announces Data from AUTO1/22 Trial in Pediatric Acute Lymphoblastic Leukemia in an Oral Presentation at the EBMT 49th Annual Meeting

26 Apr 2023 07:06:00 By Nasdaq GlobeNewswire

Autolus Therapeutics to Host Virtual Capital Markets Day

25 Apr 2023 07:00:01 By Nasdaq GlobeNewswire

Autolus Therapeutics to Report First Quarter 2023 Financial Results and Host Conference Call on May 4, 2023

20 Apr 2023 07:00:00 By Nasdaq GlobeNewswire

Autolus Therapeutics Announces Publication in Molecular Therapy

04 Apr 2023 07:00:00 By Nasdaq GlobeNewswire

Autolus Therapeutics announces resignation of Chief Financial Officer

14 Mar 2023 07:00:00 By Nasdaq GlobeNewswire

Autolus Therapeutics Has No Business Relationship with Silicon Valley Bank

13 Mar 2023 07:00:00 By Nasdaq GlobeNewswire

Autolus Therapeutics Reports Full Year 2022 Financial Results and Operational Progress

07 Mar 2023 07:00:01 By Nasdaq GlobeNewswire

Autolus Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on March 7, 2023

15 Feb 2023 07:00:00 By Nasdaq GlobeNewswire

Autolus Therapeutics announces Board changes

20 Jan 2023 07:00:00 By Nasdaq GlobeNewswire

Autolus Therapeutics Announces Collaboration with Cabaletta Bio for Use of Autolus’ Safety Switch System in Cell Therapies for Autoimmune Disease

09 Jan 2023 07:00:02 By Nasdaq GlobeNewswire

Autolus Announces Partial Exercise of Underwriters' Option to Purchase Additional ADSs

21 Dec 2022 16:01:00 By Nasdaq GlobeNewswire

Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2022

12 Dec 2022 10:00:00 By Nasdaq GlobeNewswire

Autolus Announces Pricing of Public Offering

08 Dec 2022 21:11:25 By Nasdaq GlobeNewswire

Autolus Announces Proposed Public Offering in the United States

08 Dec 2022 16:03:13 By Nasdaq GlobeNewswire